Inhalant treatment is unusual in one way, and it should shape the whole decision. The risk is front-loaded. Federal research summaries say the strong chemicals in solvents and sprays can set off fast, irregular heart rhythms [1]. That can cause fatal heart failure within minutes of use [1]. The toxic chemicals in inhalants, and the way people use them, can also cause a person to stop breathing [1]. These effects are known as sudden sniffing death, and they can happen even the first time a person uses [1].
That changes the math on waiting. This page covers when treatment helps and what an assessment weighs. It covers whether detox comes first, how the levels of care differ here, which therapies have evidence, where medication fits, and what it costs. Our page on inhalant abuse and addiction covers the substances themselves.
If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental health crisis, call or text 988.
When Inhalant Use Becomes Something Treatment Can Help With
The threshold is not frequency. It is whether stopping has become difficult, and whether the reasons to stop are being outrun by the reasons not to.
Federal research summaries describe the pattern in plain terms. Many people who use inhalants report a strong need to keep using even when they want to stop [1]. That is most common in people who have used for long periods or over many days [1]. Regular use can bring on withdrawal symptoms after someone stops, including irritability, anxiety and craving [1]. Mental health problems and trouble carrying out daily responsibilities are also named as symptoms of inhalant use disorder [1].
For a parent or partner, the signs to watch are specific rather than vague. Federal summaries list chemical odors on breath or clothing [1]. They list paint or other stains on the face, hands or clothing [1]. They list hidden empty spray paint or solvent cans and chemical-soaked rags [1]. And they list a dazed look, slurred speech, nausea, poor coordination, anxiety, irritability and low mood [1].
None of that is a diagnosis. It is a reason to book an assessment, not a reason to open with an accusation.
Assessment: What a Clinician Looks For Before Recommending a Level of Care
The assessment appointment decides the level of care. It is worth going into it knowing what is being weighed.
Four things dominate, and two are specific to this substance. The first is what is being inhaled. Solvents, aerosols, gases and nitrites behave differently in the body, so the answer changes the plan.
The second is how the brain is working. Federal summaries call damage to the brain and nervous system perhaps the most significant toxic effect of long-term exposure [1]. Chronic use of solvents such as toluene affects the protective sheath around certain nerve fibers [1].
The other two are the usual ones. What else is being used. And what the mental health picture looks like, including the anxiety and low mood federal summaries name among the signs [1].
Federal research guidance asks for a plan tailored to the person, not to the drug. It should address their own drug use patterns and their drug-related medical, mental and social problems [2]. Here that has teeth. A cognitive assessment may change the plan more than the frequency of use does. Our rehab process page explains where the assessment sits.
Does Inhalant Use Need Medical Detox First?
Sometimes, and the question is settled clinically rather than by category.
Federal summaries describe withdrawal after regular inhalant use, naming irritability, anxiety and craving [1]. That is a real withdrawal syndrome, and it is one a program can support somebody through.
What usually decides it is what else is in the picture. Alcohol and sedatives are the classes where withdrawal itself turns dangerous. There, withdrawal management is a medical procedure rather than a comfort measure. Federal guidance sets out the settings where it happens: a physician’s office, freestanding programs, partial hospitalization, and acute care inpatient units [3]. It maps those onto the five adult detox levels used by the American Society of Addiction Medicine, each with its own staffing [3].
Whatever the setting, detox starts treatment. It does not replace it. Federal guidance states that detoxification is not substance abuse treatment and rehabilitation [4]. A detox program is not built to resolve the long-standing psychological, social and behavioral problems that come with long-term use [4]. Federal research guidance is blunter still: detox alone, with no treatment after it, generally leads back to drug use [2].
Our medical detox page describes that level of care, and our page on withdrawal symptoms compares classes.
Where inhalant treatment can start in Florida
The Recovery Village Umatilla is our campus in Umatilla, Florida, in Lake County northwest of Orlando. It runs medical detox, residential and inpatient care, inpatient rehab for mental health, a partial hospitalization program, outpatient care and aftercare planning, and admissions can verify benefits for each level before anything is agreed.
See treatment options in Florida
Verify your insurance
The Recovery Village Umatilla is part of our family of treatment centers. See the Recovery Village Umatilla campus.
Residential Treatment for Inhalant Use, and Who It Suits
Residential care has an argument in its favor here that it does not have for every substance: the supply is in the house.
Inhalants are ordinary products. Cutting off access is not about avoiding a dealer or a street. It means changing what sits under the sink, in the garage and in the desk drawer. Where the people at home cannot do that, living at a program does the job instead.
Two other things point the same way. One is a cognitive difficulty that makes an outpatient schedule hard to keep. Federal summaries say chronic solvent use can damage parts of the brain involved in controlling thinking, movement, vision and hearing, and that long-term inhalant use can cause memory and attention problems [1]. The other is a mental health condition that needs daily clinical contact while it settles, which federal summaries flag as a common part of inhalant use disorder [1].
Our inpatient rehab page describes what living at a program involves, and our levels of care guide sets out the whole ladder.
PHP and IOP for Inhalant Use
Partial hospitalization and intensive outpatient care are the two levels most people step down into, and the choice between them is about hours and about what home looks like.
A partial hospitalization program fills most of a clinical day. The person sleeps elsewhere. An intensive outpatient program is lighter. It usually runs in blocks of a few hours, several days a week, around work, study or family.
For inhalants the deciding question is the one above, asked again. Can home support someone who returns to it every evening? Where it can, outpatient care has a real edge, because the coping skills get practiced where they are needed. Where it cannot, the program is competing with the supply cupboard.
Our outpatient rehab page covers how those schedules are built, and how long rehab takes covers the arc across both.
Therapies With the Strongest Evidence for This Substance
With no medication to lean on, the therapy is the treatment rather than an addition to it.
Federal research guidance names the behavioral approaches with evidence behind them and describes what each does. Cognitive behavioral therapy “seeks to help patients recognize, avoid, and cope with the situations in which they’re most likely to use drugs” [2]. Contingency management “uses positive reinforcement such as providing rewards or privileges for remaining drugfree, for attending and participating in counseling sessions, or for taking treatment medications as prescribed” [2]. Behavioral therapies also help people remain in treatment longer [2], and longer time in treatment is itself associated with better outcomes [7].
Two adjustments are common here, and both are worth asking about. Family involvement tends to matter more than average, because the home is part of the treatment. And where thinking is slowed, material often has to be repeated and simplified. That is a normal accommodation, not a sign the program is failing.
Our pages on substance abuse counseling techniques and on what CBT is describe those sessions.
Medication Options, Where They Exist
No medication treats inhalant use itself, and it is more useful to say why than to leave it as an absence.
Federal research guidance lists the medications that exist, by drug class. For opioid addiction it names methadone, buprenorphine, extended-release naltrexone and lofexidine [2]. For nicotine it names nicotine replacement, bupropion and varenicline [2]. For alcohol it names naltrexone, disulfiram and acamprosate [2]. Inhalants are not on that list. Where no medication exists for a class, federal guidance says treatment consists of behavioral therapies [2].
Medication still has a place in the plan. Just not that one. Anxiety, low mood and sleep problems are treated on their own terms by a prescriber. Where opioids or alcohol are also in use, medication-assisted treatment may be part of the plan for those.
No amounts, schedules or drug choices appear on this page. Those are prescribing decisions belonging to a clinician who has examined the person.
Co-occurring Mental Health Conditions and Why They Change the Plan
Federal summaries put mental health problems in the definition of inhalant use disorder rather than beside it [1], and that is the practical reason this section exists.
Anxiety, irritability and low mood sit in the same federal list as the physical signs [1]. Read as consequences of use, they get left until the use stops. Read as conditions in their own right, they get a plan in week one. That is what federal research guidance asks for when it says a plan must address mental and social problems alongside the drug use [2].
Say what the mood has been like on the assessment call. Include the parts that are hard to say. If the answer is significant, expect the recommendation to move toward daily clinical contact. Our page on co-occurring conditions explains how both are treated together.
Paying for Inhalant Treatment and Verifying Benefits
Your policy decides this, not the substance, and a verification of benefits is how you find out what yours says.
Federal parity law sets the frame. A plan that covers mental health and substance use benefits may not treat them worse than medical care. The test is whether its requirements and limits are more restrictive than the predominant ones it applies to substantially all medical and surgical benefits in the same class [5]. Parity has a scope worth knowing. It applies to non-federal governmental plans with more than 50 employees and to private employer group plans with more than 50 employees, and to individual-market coverage [5]. Small-employer group plans are generally outside it. Non-grandfathered small-group and individual plans must still cover this care as an essential health benefit under the Affordable Care Act [5]. Marketplace plans must cover it with no annual or lifetime dollar limits [6].
For a sense of scale, our own what rehab costs page puts a 30-day intensive outpatient program at $3,000 to $10,000. It puts partial hospitalization at $350 to $450 a day. Those are DrugRehab.com’s own published ranges, not federal figures. Our insurance coverage guide lists what to ask. How to get into rehab covers the sequence, and our nationwide directory of rehab facilities shows the campuses we run.
Frequently Asked Questions
Do I need inpatient treatment for inhalant use? Possibly, and for a reason specific to this substance: the supply is usually in the house. Where access cannot realistically be removed at home, living at a program does the work environmental change would otherwise have to do. Cognitive difficulty and a mental health condition needing daily contact point the same way; federal summaries say long-term inhalant use can cause memory and attention problems. The assessment decides.
Is there a medication for inhalant addiction? No. Federal research guidance lists medications by drug class for opioids, nicotine and alcohol, and inhalants are not among the classes for which it lists one. Where no medication exists, federal guidance is that treatment consists of behavioral therapies. Anxiety, depression or sleep problems can still be treated separately by a prescriber.
How long does inhalant treatment take? Longer than the acute phase suggests. Federal research guidance holds that most people with an addiction need at least three months in treatment to significantly reduce or stop drug use, with the best outcomes at longer durations. That is time in treatment overall, across levels of care, rather than a number of nights in a bed.
Will insurance cover it? Often, though your own policy settles it. Parity law bars a plan covering these benefits from applying requirements more restrictive than the predominant ones it applies to substantially all medical and surgical benefits, and Marketplace plans must cover substance use disorder treatment with no annual or lifetime dollar limits. A benefits check gives the actual numbers.
What happens on the first call? A confidential screening rather than a commitment. Expect questions about what is being inhaled and how often, what else is being used, previous treatment, current medications, other diagnoses and what home looks like. The coverage check usually runs alongside. A clinical assessment then sets the level of care.
Sources
- National Institute on Drug Abuse. Inhalants. National Institutes of Health. https://nida.nih.gov/research-topics/inhalants
- National Institute on Drug Abuse. Drugs, Brains, and Behavior: The Science of Addiction — Treatment and Recovery. National Institutes of Health. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 2: Settings, Levels of Care, and Patient Placement. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64109/
- Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 1: Overview, Essential Concepts, and Definitions in Detoxification. Treatment Improvement Protocol (TIP) Series No. 45, SAMHSA, via NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK64119/
- Centers for Medicare and Medicaid Services. The Mental Health Parity and Addiction Equity Act (MHPAEA). https://www.cms.gov/marketplace/private-health-insurance/mental-health-parity-addiction-equity
- HealthCare.gov. Mental Health and Substance Abuse Health Coverage Options. Centers for Medicare and Medicaid Services. https://www.healthcare.gov/coverage/mental-health-substance-abuse-coverage/
- National Institute on Drug Abuse. (2012). Principles of Drug Addiction Treatment: A Research-Based Guide, 3rd edition. National Institutes of Health. https://nida.nih.gov/sites/default/files/podat-3rdEd-508.pdf
This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.
Author
Chief Medical Officer,
The Recovery Village
